GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Highnoon Laboratories Ltd (KAR:HINOON) » Definitions » Current Deferred Revenue

Highnoon Laboratories (KAR:HINOON) Current Deferred Revenue : ₨0 Mil (As of Sep. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Highnoon Laboratories Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Highnoon Laboratories's current deferred revenue for the quarter that ended in Sep. 2024 was ₨0 Mil.

Highnoon Laboratories Current Deferred Revenue Historical Data

The historical data trend for Highnoon Laboratories's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Highnoon Laboratories Current Deferred Revenue Chart

Highnoon Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Highnoon Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Highnoon Laboratories Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Highnoon Laboratories's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Highnoon Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Jail Road, 901-9th floor, Tricon Corporate Center 73-E, Lahore, PAK
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.

Highnoon Laboratories Headlines

No Headlines